Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AER-271
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Covance
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 1 Study to Assess AER-271
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
January 15, 2019
Lead Product(s) : AER-271
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Covance
Deal Size : Inapplicable
Deal Type : Inapplicable